{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:54:49Z","timestamp":1783738489246,"version":"3.55.0"},"reference-count":25,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:sec><jats:title>Objectives.<\/jats:title><jats:p>To determine the feasibility of comparing the Childhood Arthritis and Rheumatology Research<\/jats:p><jats:p>Alliance (CARRA) consensus treatment plans (CTP) in treating moderate new-onset juvenile dermatomyositis (JDM) using the CARRA registry, and to establish appropriate analytic methods to control for confounding by indication and missing data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A pilot cohort of 39 patients with JDM from the CARRA registry was studied. Patients were assigned by the treating physician, considering patient\/family preferences, to 1 of 3 CTP: methotrexate (MTX) and prednisone (MP); intravenous (IV) methylprednisolone, MTX, and prednisone (MMP); or IV methylprednisolone, MTX, prednisone, and IV immunoglobulin (MMPI). The primary outcome was the proportion of patients achieving moderate improvement at 6 months under each CTP. Statistical methods including multiple imputation and inverse probability of treatment weighting were used to handle missing data and confounding by indication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Patients received MP (n = 13), MMP (n = 18) and MMPI (n = 8). Patients in all CTP had significant improvement in disease activity. Of the 36 patients who remained in our pilot study at 6 months, 16 (44%) of them successfully achieved moderate improvement at 6 months (6\/13, 46% for MP; 7\/15, 47% for MMP; 3\/8, 38% for MMPI). After correcting for confounding, there were no statistically significant pairwise differences between the CTP (<jats:italic>P<\/jats:italic>= 0.328\u20130.88).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>We gained valuable experience and insight from our pilot study that can be used to guide the design and analysis of comparative effectiveness studies using the CARRA registry CTP approach. Our analytical methods can be adopted for future comparative effectiveness studies and applied to other rare disease observational studies.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.190494","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T16:15:23Z","timestamp":1585757723000},"page":"114-122","source":"Crossref","is-referenced-by-count":14,"title":["Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study"],"prefix":"10.3899","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-1276","authenticated-orcid":false,"given":"Kuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-6399","authenticated-orcid":false,"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1689","authenticated-orcid":false,"given":"Adam M.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Saarela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Bout-Tabaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Dvergsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence K.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-0207","authenticated-orcid":false,"given":"Sarah","family":"Ringold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Rouster-Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Tesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Wahezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-9665","authenticated-orcid":false,"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2022062114101691000_48.1.114.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"2022062114101691000_48.1.114.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11122"},{"key":"2022062114101691000_48.1.114.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2007.07.002"},{"key":"2022062114101691000_48.1.114.4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11926-011-0167-9","article-title":"Juvenile dermatomyositis","volume":"13","author":"Batthish","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"2022062114101691000_48.1.114.5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128072-200204050-00004","article-title":"Juvenile dermatomyositis: recognition and treatment","volume":"4","author":"Reed","year":"2002","journal-title":"Paediatr Drugs"},{"key":"2022062114101691000_48.1.114.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.21378"},{"key":"2022062114101691000_48.1.114.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60955-1"},{"key":"2022062114101691000_48.1.114.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01021-1"},{"key":"2022062114101691000_48.1.114.9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090953"},{"key":"2022062114101691000_48.1.114.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.30475"},{"key":"2022062114101691000_48.1.114.11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children\u2019s Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2022062114101691000_48.1.114.12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res"},{"key":"2022062114101691000_48.1.114.13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.40395","article-title":"The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: toward comparative effectiveness in the pediatric rheumatic diseases","volume":"70","author":"Ringold","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2022062114101691000_48.1.114.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.153718"},{"key":"2022062114101691000_48.1.114.15","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/jdv.13725","article-title":"European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology","volume":"30","author":"Enk","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022062114101691000_48.1.114.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211400"},{"key":"2022062114101691000_48.1.114.17","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8"},{"key":"2022062114101691000_48.1.114.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.20179"},{"key":"2022062114101691000_48.1.114.19","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"2022062114101691000_48.1.114.20","doi-asserted-by":"crossref","unstructured":"van Buuren S. Flexible imputation of missing data. Chapman and Hall\/CRC; 2018.","DOI":"10.1201\/9780429492259"},{"key":"2022062114101691000_48.1.114.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5753"},{"key":"2022062114101691000_48.1.114.22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12969-017-0157-1","article-title":"Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans","volume":"15","author":"Kimura","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2022062114101691000_48.1.114.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.11.020"},{"key":"2022062114101691000_48.1.114.24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1740774518761367","article-title":"Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST)","volume":"15","author":"Nigrovic","year":"2018","journal-title":"Clin Trials"},{"key":"2022062114101691000_48.1.114.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.06.003"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.190494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T07:12:52Z","timestamp":1722669172000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.190494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,1]]},"published-print":{"date-parts":[[2021,1,1]]}},"alternative-id":["10.3899\/jrheum.190494"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.190494","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}